Cannabis Clinical Trials Decriminalization Safety 
Cannabis Law Report
SEPTEMBER 23, 2022
Senate Bill 519 would have decriminalized the personal possession of certain psychedelic substances, legalized life-saving public health interventions, and studied future approaches to increasing use of psychedelics. The continued criminalization of all drugs and the people who use them increases harms to public health and safety.
Canna Law Blog
NOVEMBER 6, 2021
To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
JANUARY 28, 2019
A medical cannabis bill has been filed in the Kentucky General Assembly every year since 2013. Cannabis reform has stalled recently because of opposition from Kentucky’s Senate leadership. Danny Bentley, R-Russell, erroneously compared cannabis to “snake oil remedies of the 1800s,” according to a WDRB-TV report.
NORML
JANUARY 4, 2019
Separate provisions in the bill exclude cannabidiol from the federal definition of marijuana, permit VA doctors to authorize medical cannabis access to qualified patients, and remove undue federal barriers to clinical trial research to better assess the safety and efficacy of medical cannabis. Pennsylvania.
Cannabis Law Report
JULY 1, 2021
Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. cities and the State of Oregon have decriminalized them, and last November, Oregon voters legalized the supervised administration of psilocybin. Background. Due to their therapeutic and commercial potential, the U.S.
Cannabis Law Report
JULY 9, 2021
Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra. The state of the law on psychedelic substances is in flux. Id ; 21 CFR 312.1-10;
The Cannigma
AUGUST 31, 2021
Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge. We have a ways to go,” Tan said.
Expert insights. Personalized for you.
52 
Let's personalize your content